Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported on Tuesday that it expects fourth quarter revenues of $14.9 million, up 13 percent year over year.

The company also reported preliminary full-year 2016 revenues of $49.2 million, up 25 percent compared to 2016.

The preliminary revenues just beat the average Wall Street estimate of $14.8 million for Q4 and $49.1 million for 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.